Supplemental material, sj-docx-1-cra-10.1177_11795484221119316 for Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19 by Rosie S. Jones, Patricia S. Smith, Paul H. Berg, Amparo de la Peña, Paul P. Cook, Imad Shawa, Kathleen M. Kioussopoulos, Yu Hu and Robert J. Schott in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine